Annexon biosciences to present at the 2022 jefferies healthcare conference

Brisbane, calif., june 02, 2022 (globe newswire) -- annexon, inc. (nasdaq: annx), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that douglas love, esq., president and chief executive officer, will present at the 2022 jefferies healthcare conference on thursday, june 9, 2022 at 10:30 a.m. et in new york city.
ANNX Ratings Summary
ANNX Quant Ranking